Celon Pharma S.A. Logo

Celon Pharma S.A.

An integrated pharmaceutical company researching and manufacturing modern drugs.

CLN | WAR

Overview

Corporate Details

ISIN(s):
PLCLNPH00015 (+3 more)
LEI:
259400Q0ERJT0NC5DT24
Country:
Poland
Address:
KAZUŃ NOWY MARYMONCKA 15, 05-152 KAZUŃ NOWY

Description

Celon Pharma S.A. is an integrated pharmaceutical company that conducts advanced research and manufactures modern drugs. The company is engaged in the development, production, distribution, and marketing of therapeutic solutions. Its primary focus is on developing treatments for cancers, neurological diseases, diabetes, and other metabolic disorders. As a marketing authorization holder, Celon Pharma manages the full product lifecycle, from scientific research and development to commercialization, aiming to improve patient health and quality of life.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-19 17:13
Raport 3 kwartał 2025
Polish 2.3 MB
2025-10-10 15:36
Statut - tekst jednolity
Polish 405.4 KB
2025-10-10 15:36
Rejestracja zmiany Statutu Spółki - Content (PL)
Polish 1.7 KB
2025-10-03 17:06
Zawarcie przez spółkę zależną umowy z generalnym wykonawcą inwestycji - Content…
Polish 2.7 KB
2025-10-02 17:55
Podsumowanie spotkania z Food and Drug Administration, (FDA) typu B dla CPL'36…
English 3.4 KB
2025-10-02 17:55
Podsumowanie spotkania z Food and Drug Administration, (FDA) typu B dla CPL'36…
Polish 3.2 KB
2025-09-17 17:55
Raport z przeglądu
Polish 218.2 KB
2025-09-17 17:55
Raport z przeglądu
Polish 437.5 KB
2025-09-17 17:55
Sprawozdanie z działalności Zarządu
Polish 953.2 KB
2025-09-17 17:55
Sprawozdanie finansowe H12025
Polish 1.6 MB
2025-09-11 11:12
Aktualizacja informacji dotyczącej przekazywania raportów okresowych w 2025 rok…
Polish 1.9 KB
2025-08-04 15:16
Uzgodnienie z Europejskim Bankiem Odbudowy i Rozwoju głównych warunków udzielen…
Polish 1.5 KB
2025-07-16 21:15
zal01_TCM_Celon_Notification_Form.pdf
English 89.7 KB
2025-07-16 21:15
Otrzymanie zawiadomienia o przekroczeniu progu 5% udziału w ogólnej liczbie gło…
Polish 1.1 KB
2025-06-26 21:39
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na Zwyczajnym Walnym Zg…
Polish 888 bytes

Automate Your Workflow. Get a real-time feed of all Celon Pharma S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Celon Pharma S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Celon Pharma S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.